Abstract:Background Findings from previous studies linking brain-derived neurotrophic factor (BDNF) and schizophrenia are inconsistent and few studies have assessed the relationship between BDNF C270T gene polymorphisms and the clinical and cognitive symptoms of schizophrenia. Aim Compare the prevalence of the BDNF C270T gene polymorphisms between patients with schizophrenia and controls and, in the patients, assess the relationship of genotypes to the severity of symptoms. Methods BDNF C270T genotype and allele frequency were measured using Polymerase Chain Reaction methods in 224 drug-free patients with schizophrenia and 220 controls. Psychotic symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive functioning was assessed using the Wisconsin Card Sorting Test (WCST) and the Trail Making Test (TMT). In the patient group, differences in severity of symptoms across the three genotypes (i.e., C/C, C/T, and T/T) of C270T were assessed using one-way analysis of variance. Results The frequency of the T allele was much higher in patients than in controls (15.6% vs. 4.3%, χ2=31.47, p<0.001) and the C/T genotype was more common among patients than controls (27.7% vs. 7.7%, χ2=34.93, p<0.001). Compared to controls, patients performed poorly on all the cognitive tests, but there were no significant differences in the cognitive measures between patients with the three different genotypes. The total PANSS score, the PANSS negative symptoms subscale score, and the PANSS general psychopathology subscale score were not significantly different between the three groups of patients. However, the PANSS positive symptoms subscale score showed a small, statistically significant elevation in the severity of positive symptoms in the C/T genotype compared to the C/C genotype. Conclusion We confirm previous findings about differences in the prevalence of the BDNF C270T gene polymorphisms in schizophrenia, but do not find strong evidence of a relationship between different genotypes and the severity of the clinical or cognitive symptoms of schizophrenia. Clinical and cognitive symptoms in schizophrenia fluctuate over the course of the illness and with treatment, so stable, individual-specific measures of these parameters (that is, traits) need to be identified before it will be possible to definitively assess their relationship to different genotypes.

The Contingent Negative Variation In Patients With Deficit Schizophrenia And Or Bipolar I Disorder Patients With Psychotic Features Measurement And Correlation With Clinical Characteristics

Contingent negative variation in patients with deficit schizophrenia or bipolar I disorder with psychotic features: Measurement and correlation with clinical characteristics

Contingent Negative Variation in First Episode Deficit and Non-Deficit Schizophrenia:A Comparative Study

Contingent Negative Variation of Mood Disorder Patients

A Follow Up Study of Contingent Negative Variation of Schizophrenics

Early and late contingent negative variation (CNV) reflect different aspects of deficits in schizophrenia

P300 components of auditory event-related potentials in first episode deficit and non-deficit schizophrenia

Study on contingent negative variation in anxiety disorder

A Comparative Study about Mismatch Negativity Between Patients with Schizophrenia and Bipolar I Disorder

Controlled study of mismatched negativity in first-episode deficit and non-deficit forms schizophrenia patients who not received treatment

Multi-components of evoked-brain potentials in deficit and nondeficit schizophrenia.

The Contribution of the Contingent Negative Variation (CNV) to Goal Maintenance

P300 components of auditory event-related potentials in bipolar and unipolar depressive disorder

Aberrant Spontaneous Neural Activity and Correlation with Evoked-Brain Potentials in First-Episode, Treatment-Naïve Patients with Deficit and Non-Deficit Schizophrenia.

Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables

Aberrant Cerebellar Neural Activity and Cerebro-Cerebellar Functional Connectivity Involving Executive Dysfunction in Schizophrenia with Primary Negative Symptoms.

Convergent and divergent genes expression profiles associated with brain-wide functional connectome dysfunction in deficit and non-deficit schizophrenia

Convergence and Divergence of Brain Network Dysfunction in Deficit and Non-deficit Schizophrenia

Opposite effects of positive and negative symptoms on resting-state brain networks in schizophrenia

Positive and negative symptom profile schizophrenia and abnormalities in the P300 component of the event-related potential: a longitudinal controlled study.

Relationship Between Brain-Derived Neurotrophic Factor Gene C270T Polymorphisms and the Psychotic Symptoms and Cognitive Functioning of Patients with Schizophrenia.